In 2012, a federal court of appeals struck down an FDA rule requiring graphic health warnings on cigarettes as violating First Amendment commercial speech protections. Tobacco product inserts and onserts can more readily avoid First Amendment constraints while delivering more extensive information to tobacco users, and can work effectively to support and encourage smoking cessation. This paper examines FDA’s authority to require effective inserts and onserts and shows how FDA could design and support them to avoid First Amendment problems. Through this process, the paper offers helpful insights regarding how key Tobacco Control Act provisions can and should be interpreted and applied to follow and promote the statute’s purposes and objectiv...
The FDA has recently passed sweeping regulations, which classifies and then regulates electronic cig...
This paper seeks (1) to provide the background necessary to understand current commercial speech jur...
Professor Richard Merrill contends that the Federal Food, Drug, and Cosmetic Act does not grant the ...
In 2012, a federal court of appeals struck down an FDA rule requiring graphic health warnings on cig...
Tobacco use is one of the most catastrophic public health issues facing the world today. The recentl...
When Congress passed the nation’s first comprehensive tobacco bill in 2009, it replaced the familiar...
In 1996 the Food and Drug Administration (FDA) promulgated regulations affecting the advertising, sa...
With the enactment of the Family Smoking Prevention and Tobacco Control Act of 2009, Congress launch...
This article explores whether a graphic warning is possible or preferable in the government\u27s fig...
Regulation of commercial speech is a major component of federal regulation of tobacco products. Sinc...
This Article evaluates the constitutionality of a representative series of congressional proposals t...
Congress passed the Tobacco Control Act (TCA) in 2009, giving the FDA the authority to regulate toba...
In 2010, the Food and Drug Administration passed a rule revising compelled disclaimers on tobacco pr...
At a press conference held on August 23, 1996, just one year after initially revealing his plans, Pr...
The government’s latest attempt to protect consumers from the perils of tobacco use is in jeopardy. ...
The FDA has recently passed sweeping regulations, which classifies and then regulates electronic cig...
This paper seeks (1) to provide the background necessary to understand current commercial speech jur...
Professor Richard Merrill contends that the Federal Food, Drug, and Cosmetic Act does not grant the ...
In 2012, a federal court of appeals struck down an FDA rule requiring graphic health warnings on cig...
Tobacco use is one of the most catastrophic public health issues facing the world today. The recentl...
When Congress passed the nation’s first comprehensive tobacco bill in 2009, it replaced the familiar...
In 1996 the Food and Drug Administration (FDA) promulgated regulations affecting the advertising, sa...
With the enactment of the Family Smoking Prevention and Tobacco Control Act of 2009, Congress launch...
This article explores whether a graphic warning is possible or preferable in the government\u27s fig...
Regulation of commercial speech is a major component of federal regulation of tobacco products. Sinc...
This Article evaluates the constitutionality of a representative series of congressional proposals t...
Congress passed the Tobacco Control Act (TCA) in 2009, giving the FDA the authority to regulate toba...
In 2010, the Food and Drug Administration passed a rule revising compelled disclaimers on tobacco pr...
At a press conference held on August 23, 1996, just one year after initially revealing his plans, Pr...
The government’s latest attempt to protect consumers from the perils of tobacco use is in jeopardy. ...
The FDA has recently passed sweeping regulations, which classifies and then regulates electronic cig...
This paper seeks (1) to provide the background necessary to understand current commercial speech jur...
Professor Richard Merrill contends that the Federal Food, Drug, and Cosmetic Act does not grant the ...